Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708... von Zwart, K., Braat, M.N.G.J.A., van der Baan, F.H., May, A.M., Roodhart, J.M.L., Al-Toma, D., Otten, J.M.M.B., Los, M., Oostergo, T., Fijneman, R.J.A., van Dodewaard-de Jong, J.M., Punt, C.J.A, Meijer, G., Lagendijk, J.J.W., Koopman, M., Intven, M., Bol, G.M.

Volltext

KRAS variant rs61764370 is not associated with ovarian cancer risk or survival in the Ovarian Cancer Association Consortium (OCAC) or Consortium of Modifiers of BRCA1 and BRCA2 (CI... von van der Baan, F.H, Johnatty, S.E, Chenevix-Trench, G, Pharoah, P.D.P, Rookus, M.A, Goode, E

Volltext

550P The impact of mismatch repair status on accuracy of clinical staging in upfront resected stage II/III rectal cancer in the Netherlands von Lunenberg, R.A., Franken, I.A., Braat, M.N.G.J.A., Elferink, M., van der Baan, F.H., Koopman, M., Vink, G., Intven, M., Sijtsma, F., Roodhart, J.M.L.

Volltext

569P Mismatch repair deficient, stage II/III rectal cancer: Real-world patient, tumour, and treatment characteristics in the Netherlands von Lunenberg, R.A., Franken, I.A., van der Baan, F.H., Sijtsma, F.P.C., Vink, G., Koopman, M., Intven, M., Braat, M.N.G.J.A., Moons, L., Laclé, M., Elferink, M., Boklage, S.H., Garside, J., Wuijtswinkel, R.V., Roodhart, J.M.L.

Volltext

CN72 - Patient reported outcomes during immunotherapy: Symptom burden in daily clinical practice von Koldenhof, J.J., Verberne, E.G., Verheijden, R.J., Tonk, E., van der Baan, F.H., van Lindert, A., van der Stap, J., Teunissen, S.C., Witteveen, P.O., Suijkerbuijk, K.P.M.

Volltext

Patient reported outcomes during immunotherapy: Symptom burden in daily clinical practice von Koldenhof, J.J., Verberne, E.G., Verheijden, R.J., Tonk, E., van der Baan, F.H., van Lindert, A., van der Stap, J., Teunissen, S.C., Witteveen, P.O., Suijkerbuijk, K.P.M.

Volltext

Added value of pharmacogenetic testing in predicting statin response: results from the REGRESS trial von van der Baan, F H, Knol, M J, Maitland-van der Zee, A H, Regieli, J J, van Iperen, E P A, Egberts, A C G, Klungel, O H, Grobbee, D E, Jukema, J W

Volltext

Personalized Medicine : Pharmacogenetic Testing in Drug Development and Clinical Practice von van der Baan, F.H

Volltext bestellen

Genetic susceptibility to radiation-induced breast cancer after Hodgkin Lymphoma von Opstal-van Winden, A.W.J, de Haan, H.G, Hauptmann, M, Schmidt, M.K, Broeks, A, Russell, N.S, Janus, C.P.M, Krol, A.D.G, van der Baan, F.H, De Bruin, M.L, van Eggermond, A.M, Dennis, J, Anton Culver, H, Haiman, C.A, Sawyer, E.J, Cox, A, Devilee, P, Hooning, M.J, Peto, J, Couch, F.J, Pharoah, P, Orr, N, Easton, D.F, Aleman, B.M.P, Strong, L.C, Bhatia, S, Cooke, R, Robison, L.L, Swerdlow, A.J, van Leeuwen, F.E

Volltext bestellen

Left ventricular pressure-volume relationships before and after cardiomyoplasty in patients with heart failure von SCHREUDER, J. J, VAN DER VEEN, F. H, VOLTERRANI, M, KAULBACH, H.-G, BAAN, J, WELLENS, H. J. J, VAN DER VELDE, E. T, DELAHAYE, F, ALFIERI, O, JEGADEN, O, LORUSSO, R, JANSEN, J. R. C, HOEKSEL, S. A. A. P, FINET, G

Volltext